Target miRNA information. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Multivariable mixed effect logistic regression for chills, with individual ID and stimulus as a random effect. Individual intercept variance = 1.02 and stimuli intercept variance =... by Felix Alexandre Schoeller (20988295)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Fig 5 - by Mísia Helena da Silva Ferro (20623666)

Subjects:

Regression analysis results with depressive symptoms. by Oejin Shin (20855617)

Subjects:

Expression level (2^-ΔCq) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Pathways with potential involvement of the target miRNAs. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Regression analysis results with self-rated health. by Oejin Shin (20855617)

Subjects:

The table provides details about the six different videos used in the study. For each video, a brief description, its length, and its chills ratio (CR) from past ChillsDB studies a... by Felix Alexandre Schoeller (20988295)

Subjects:

Sequence analysis results. by Oejin Shin (20855617)

Subjects:

Expression level (2^-ΔCq) of microRNA in the prefrontal cortex of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

A. Bar chart showing the percentage of participants experiencing chills in response to various stimuli, ordered by descending frequency. by Felix Alexandre Schoeller (20988295)

Subjects:

Descriptive analysis. by Oejin Shin (20855617)

Subjects:

Changes in the neutrophil count. by Lu Yang (30847)

“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”

Changes in the platelet count. by Lu Yang (30847)

“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”

Changes in the white blood cell count. by Lu Yang (30847)

“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”

Changes in the hemoglobin. by Lu Yang (30847)

“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”

WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

“…<div><p>Background</p><p>To study the efficacy and safety of Polyethylene glycolated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in the prevention of neutropenia during concurrent chemoradiotherapy for nasopharyngeal carcinoma (NPC).…”